Currus Biologics
Company Details
Status: Private
Employees: 1-10
Location:
Melbourne, Victoria, Australia
Type:
sample
Technology:
sample
sample
sample
sample
About: Currus Biologics is utilising its proprietary BEAT technology to develop CAR-T cell therapies for the treatment of solid tumour cancers, traditionally difficult to treat with current CAR-T cell therapies.
Currus Biologics’ proprietary Bispecific Engagers of Antigen Presenting Cells and T cells (BEAT) technology overcomes many of the challenges presented when treating solid tumours with traditional CAR-T cell therapy, demonstrating CAR-T cell proliferation and persistence, CAR-T cell trafficking to the tumour and immunological memory extending to additional antigens.
Currus Biologics is a privately held biotechnology company based in Melbourne, Australia.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Currus Biologics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.